|
|
|
|
Explore how automation can enhance topical drug development — from pre-formulation studies to performance testing — ultimately supporting more efficient, reliable, and patient-friendly therapies.
|
|
|
|
|
Traditional drug models can fail to predict performance in skin. Advanced, multifactorial ex vivo disease models directly address inflammation and infection to significantly de-risk formulation development.
|
|
|
|
|
Regulators are focused on in vitro methods to prove bioequivalence, but differences in guidance and a new emphasis on matching the physical structure of reference products remain a challenge.
|
|
|
|
|
Novel therapeutics are driving demand for alternative drug delivery methods. Find the latest approaches and understand the formulation challenges and benefits for specific diseases.
|
|
|
|
|
Integration of robotics and automated systems across laboratory services significantly decreases experimental timelines, tightens precision, and enhances scientists' capacity for critical thinking.
|
|
|
